Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report)’s share price dropped 6% during trading on Thursday . The company traded as low as $0.33 and last traded at $0.33. Approximately 200 shares traded hands during trading, a decline of 20% from the average daily volume of 250 shares. The stock had previously closed at $0.35.
Zelira Therapeutics Price Performance
The company has a fifty day simple moving average of $0.39 and a two-hundred day simple moving average of $0.45.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Recommended Stories
- Five stocks we like better than Zelira Therapeutics
- Investing In Automotive Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
- What is Forex and How Does it Work?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to trade using analyst ratings
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
